Bone marrow transplantation and stem cell therapies have been used for the treatment of common variable immunodeficiency (CVID) and other life-threatening medical disorders. This is the first known case report in the medical literature describing improvement of both Lyme disease and CVID with human embryonic stem cell therapy.
Keywords: Borrelia burgdorferi; Lyme disease; common variable immunodeficiency; human embryonic stem cell therapy; post‐treatment Lyme disease syndrome.